Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1) > Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1):68-76

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   Freefree

Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1):68-76

DOI: 10.23736/S0392-0488.17.05795-9

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Pathways in melanoma development

Tal H. ERLICH 1, David E. FISHER 1, 2

1 Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA; 2 Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA


PDF


This review aimed to summarize the current advances in melanoma research and their clinical relevance. Until recently, melanoma was considered an incurable disease. However, in recent years tremendous advances have been made in therapeutics. This is due to profound understanding of the molecular pathways involved in melanoma development. Although new targets are always emerging, understanding how to overcome resistance to current treatments is of great interest.


KEY WORDS: Melanoma - Molecular targeted therapy - Immunotherapy

top of page